Indications |
Subcutaneous Relapsing-remitting multiple sclerosis Adult: 20 mg once a day. |
Warnings / Precautions |
Pregnancy, lactation; preexisting cardiac disorders, renal impairment. Not to be given via IV or IM. |
Adverse Reactions |
Post-injection reactions eg redness, chest pain, palpitations, tachycardia, dyspnoea, asthenia, flushing, nausea, arthralgia, hypertonia and anxiety. Rarely, convulsions and hypersensitivity reactions including anaphylaxis, bronchospasm and urticaria. Pain, erythema, pruritus and induration at the Inj site. Localized lipoatrophy. |
Drug Interactions |
Concurrent corticosteroid therapy. See Below for More glatiramer acetate Drug Interactions |
Mechanism of Actions |
Glatiramer acetate is an immunomodulating drug comprising synthetic polypeptides. |
ATC Classification |
L03AX13 - glatiramer acetate ; Belongs to the class of other immunostimulants. |
Available As |
|
Glatiramer
Post Review about Glatiramer Click here to cancel reply.
Glatiramer Containing Brands
Glatiramer is used in following diseases
Drug - Drug Interactions of Glatiramer
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.